This creates maximum separation between the two medications and reduces the chance that tirzepatide delayed gastric emptying from the previous day interferes with your morning levothyroxine absorption
If you are transporting the medication, make sure to keep it steady and avoid sudden jolts
TAKEAWAY Awareness of GLP-1 drugs intended for weight-loss purposes increased from 80% in 2024 to 91% in 2026 among US adults
We set out the types of patents that have been filed and granted, the period of patent protection, and the potential market monopoly for these two leading GLP-1 receptor agonists underscoring their role in a financialized pharmaceutical system
Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects
The incidence is typically highest during the initial weeks of treatment and during dose escalation periods